EFM
EDIT icon

E Fund Management’s Editas Medicine EDIT Stock Holding History

E Fund Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,051
Closed -$60.9K – 362
2024
Q2 		$60.9K Sell
13,051
-25,031
-66% -$141K ﹤0.01% 312
2024
Q1 		$283K Buy
38,082
+18,948
+99% +$157K 0.02% 284
2023
Q4 		$194K Sell
19,134
-6,321
-25% -$55.5K 0.01% 287
2023
Q3 		$199K Sell
25,455
-5,468
-18% -$46.9K 0.02% 262
2023
Q2 		$254K Sell
30,923
-7,932
-20% -$69.1K 0.02% 239
2023
Q1 		$282K Sell
38,855
-1,525
-4% -$13.6K 0.02% 236
2022
Q4 		$358K Buy
40,380
+10,288
+34% +$113K 0.03% 201
2022
Q3 		$368K Sell
30,092
-9,249
-24% -$144K 0.03% 200
2022
Q2 		$465K Buy
39,341
+21,529
+121% +$288K 0.04% 158
2022
Q1 		$339K Buy
+17,812
New +$331K 0.01% 170

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

E Fund Management's EDIT Position: Q3 2024 in Review

E Fund Management sold out of Editas Medicine (EDIT) in Q3 2024, closing a stake of 13,051 shares — an estimated $60.9K sold.

E Fund Management first reported a position in EDIT in Q1 2022 and held it in 10 quarters. The position peaked at $465K in Q2 2022. 229 funds tracked by Wall St. Rank hold EDIT as of Q3 2024.

  • E Fund Management reported no remaining Editas Medicine position as of Q3 2024 after selling out during the quarter.
  • E Fund Management sold 13,051 Editas Medicine shares in Q3 2024, an estimated $60.9K.
  • E Fund Management first reported a position in Editas Medicine in Q1 2022 and held it in 10 quarters.
  • E Fund Management's Editas Medicine position peaked at $465K in Q2 2022.
  • 229 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2024.

Based on E Fund Management's 13F filing for Q3 2024, filed 13 Nov 2024.